Last Updated: May 20, 2026

MECLIZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Meclizine patents expire, and what generic alternatives are available?

Meclizine is a drug marketed by Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Aurobindo Pharma Usa, Bundy, Chartwell Rx, Epic Pharma Llc, Heritage, Jubilant Cadista, Kv Pharm, Rising, Sandoz, Sciegen Pharms, Senores Pharms, Strides Pharma Intl, Superpharm, UDL, Vangard, Watson Labs, and Zydus Lifesciences. and is included in thirty-seven NDAs.

The generic ingredient in MECLIZINE is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Meclizine

A generic version of MECLIZINE was approved as meclizine hydrochloride by ZYDUS LIFESCIENCES on June 23rd, 2020.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MECLIZINE?
  • What are the global sales for MECLIZINE?
  • What is Average Wholesale Price for MECLIZINE?

US Patents and Regulatory Information for MECLIZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 084092-003 May 22, 1989 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ivax Sub Teva Pharms MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 083784-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vangard MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 087877-001 Apr 20, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Superpharm MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 089113-001 Aug 20, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vangard MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 087620-001 Jan 4, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Heritage MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 205136-003 Feb 22, 2019 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Jubilant Cadista MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 040659-001 Jun 4, 2010 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.